CellaVision AB
STO:CEVI
CellaVision AB
Long-Term Investments
CellaVision AB
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Long-Term Investments
kr2.7m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
30%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Long-Term Investments
kr34m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Long-Term Investments
kr8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
107%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Long-Term Investments
kr47m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Long-Term Investments
kr862m
|
CAGR 3-Years
91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's Long-Term Investments?
Long-Term Investments
2.7m
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Long-Term Investments amounts to 2.7m SEK.
What is CellaVision AB's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
30%
Over the last year, the Long-Term Investments growth was -40%. The average annual Long-Term Investments growth rates for CellaVision AB have been -51% over the past three years , -35% over the past five years , and 30% over the past ten years .
You don't have any saved screeners yet